Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for January 2010
January 4, 2010
- Novartis Looks to Buy Out Alcon for $38.5 Billion
- Study Eyes Epileptics' Use of Generic Drugs
- FDA, Health Organizations to Study Safety of Medications Taken During Pregnancy
- Dicerna Signs Research Collaboration and License Agreement for Drug Delivery Systems and Dicer Substrate siRNA (DsiRNA) Pharmaceuticals with Kyowa Hakko Kirin
- Biogen Idec Announces President and Chief Executive Officer James C. Mullen to Retire
January 5, 2010
- Man Pleads Guilty to Stealing 110 Pounds of Meth Ingredient
- Socialite Daughter of New York Jets Owner Has Died
- Genzyme Signs Manufacturing Deal with Hospira
- Pfizer Gets European OK for Intravenous Revatio
- Researchers from Wayne State University, University of Michigan, Harvard and UCLA Report Too Few Americans with Major Depressive Disorder Receive Adequate Care
- Lilly In New Patent Fight For Chemotherapy Drug
- Medicines Co. Suing Teva, Pliva Again Over Patent
- J&J Heiress Dies at 30
- Pfizer Gets European OK for Intravenous Revatio
- Elusys Could Get $143M In Anthrax Treatment Funds
- Genzyme Signs Manufacturing Deal With Hospira
- Keryx Agrees With FDA on Kidney Drug Trial Design
January 6, 2010
- Daiichi Sankyo's Unit Buys US PharmaForce
- FDA Drug Approvals Mostly Flat In 2009
- Penn Study Shows Antidepressants Work Best for Severe Depression, Provide Little to No Benefit Otherwise
- FDA Cancels Meeting To Review Lilly's Cymbalta
- Ensemble Discovery Initiates Collaboration with Pfizer
- Luitpold Pharmaceuticals Inc. Acquires PharmaForce, Inc., a U.S. Specialty Injectable Pharmaceutical Company
- Phase II Clinical Trial of Gilead's Investigational Integrase-Based, Once-Daily, Fixed-Dose ?Quad? Regimen Meets 24-Week Primary Objective
- Pfizer and Strides Arcolab to Collaborate on Generic Products
- Pfizer Contracts With Indian Firm for Drug Research
- Ensemble Signs Development Deal With Pfizer
- Alnylam Pharma Gets Milestone Payment From Roche
January 7, 2010
- EU Probes Danish Drug Maker for Generic Drug Delay
- AstraZeneca Makes Deal with Generic Challenger
- Pfizer and Debiopharm collaborate to co-develop investigational compound tremelimumab (CP-675,206) in advanced melanoma
- Pfizer Enters Melanoma Partnership With Debiopharm
- San Diego Based Adventrx Is Subject Of Takeover Rumors
- Pfizer And Strides Arcolab In Generic Drug Pact
- Mannkind Shares Gain Ground Ahead Of FDA Decision
- Cephalon Sues Watson Over Sleep Drug Nuvigil
- Leadership Restructuring at McCann Healthcare Worldwide
January 8, 2010
- GSK Has Finished Making Canada's H1N1 Vaccine Order, Public Health Agency Says
- Abbott Labs Pays $22.5 Million to Settle Allegations it Blocked Generic Drug Competition
- Teva Presents Strategic Plan to Deliver Strong Growth
- Eisai Completes Acquisition of AkaRx, Inc. and Continues Development of AKR-501 for Thrombocytopenia
- Ligand Earns $1 Million in Milestone Payment from Merck & Co., Inc.
- Teva Sets Goal to Double Revenue by 2015
- Reata Pharmaceuticals Licenses Chronic Kidney Disease Drug Bardoxolone Methyl to Kyowa Hakko Kirin
- Obesity Drug Said to Reduce Sleep Apnea
- Abbott Labs Settles Antitrust Suit: $22.5 Million to be Paid in Drug Case
- CVS and Allscripts team up on e-prescribing tool
- Teva Sets Goal To Double Revenue By 2015
- Amgen Shares Dip On Anemia Drug Concerns
- Fake Drugs Getting More Sophisticated
- Molecular Insight Pharmaceuticals Announces Personnel Reduction to Align Operations With Development Activities
- France Cancels Swine Flu Vaccines Ordered From Novartis
- Industry Veteran Ron Branning Joins Genzyme to Lead Global Product Quality
- Genzyme Hires Quality Control Executive
- Rosetta Acquires Wishbone
January 11, 2010
- Kindler Reveals Some do's and don't's for Pfizer
- Genentech Says FDA Approves Actemra Arthritis Drug
- MannKind Faces FDA Delay on Inhaled Insulin
- PhRMA Adds 7 Biotech Companies to its Membership
- Report: Data About Safety, Efficacy of Top Drugs is Tough to Access
- FDA Awards Contract to Harvard Pilgrim to Develop Pilot for Safety Monitoring System
- Fanapt Launches in the U.S.
- Galapagos and Roche initiate strategic alliance in COPD
- Group DCA Finalist for NJBIZ 2009 Business of the Year
- Minority Shareholders Seek to Slow Alcon Takeover
- As Many As 25,000 Yaz Lawsuits to be Handled in Illinois
- GAO: Lack of Therapeutically Equivalent Drugs and Limited Competition May Contribute to Extraordinary Price Increases
- Charles River to Suspend Operations of Preclinical Services Massachusetts to Balance Global Capacity with Demand
January 12, 2010
- EU to Check Drug Makers' Deals with Generic Rivals
- Too Much Flu Vaccine? Shot Push This Week to Tell
- Reports Says Pfizer Will Cut About 1,200 Jobs While Merck Will Eliminate 500 Positions
- Analyst Cautious on Drug Research Outsourcing
- Investigators Say Price Hikes on Drugs Increasing
- FDA Unveils First Phase of Transparency Initiative
- FDA Warnings Associated With Reduced Atypical Antipsychotic Use Among Older Adults With Dementia
- Impact of FDA Safety Warnings Examined
- Pharmaxis Ltd. acquires TOPIGEN Pharmaceuticals Inc.
January 13, 2010
- FDA Sends Letters to Bayer HealthCare, Amylin and Cephalon
- FDA Unveils First Phase of Transparency Initiative
- FDA Letters Cite Lilly, Bayer, Amylin and Cephalon
- Genzyme 4Q Revenue Drops on Manufacturing Woes
- Serbia to Stop Import of Swine Flu Vaccines
- Poland Stands Alone in Refusing Swine Flu Vaccines
- Mexico Still Waiting for More Than Half of 30 Million Swine Flu Vaccines
- SEC Files Settled Insider Trading Charges Against Massachusetts Resident
- Manhattan Research Releases New Research on DTC's Impact on Pharma Website Visitation
- Genzyme Reports Fourth-Quarter Revenue
- Lonza Streamlines its Operations in Chemical Manufacturing
- Pfizer Exec: Wyeth Has Added Value to Drug Pipeline
- Watson Pharma Says 2009 Profit Could Beat Views
- FTC Chairman, Members of Congress Call for Legislation to End Sweetheart 'Pay-for-Delay' Deals That Keep Generic Drugs Off the Market
January 14, 2010
- Merck Upgraded on Drug Pipeline, Shares Rise
- FTC Wants Ban on Drug Settlements in Health Bill
- Did WHO Experts Fuel Swine Flu Scare?
January 15, 2010
- FDA Updates Earlier Guidance on Respiratory Treatment Spiriva HandiHaler
- AB Volvo Chairman Leaves Job to Astra's Schweitzer
- Tentative Tax Deal Marks Health Care Breakthrough
- US Doctor Accused of Fraud by Faking Research
- Last-ditch Lobbying Battle Over Biotech Drugs
- FDA Updates Earlier Guidance on Respiratory Treatment Spiriva HandiHaler
- Celgene Completes Acquisition of Gloucester Pharmaceuticals
- FDA Finds No Heart Risk With Spiriva Inhaler
- US Attorney: J&J Paid Kickbacks To Boost Sales
- Pfizer Extends N.Y. Lease Through 2010
- Blood Pressure Drugs May Help Ward Off Alzheimer's Disease and Dementia
- U.S. Files Suit Against Johnson & Johnson for Paying Kickbacks to Nation?s Largest Nursing Home Pharmacy
January 19, 2010
- FDA Warns Consumers about Counterfeit Alli
- Alcon Buys Rights to 2 Approved Eye Medications
- Alcon to Purchase Ophthalmic Pharmaceutical Assets from Sirion
- Genvec Signs Development Deal With Novartis
- GenVec Enters Collaboration on Hearing Loss Treatments With Leading Global Pharmaceutical Company
- FDA Warns About Counterfeit Weight Loss Drug Alli
- Scientist Blames Pfizer For Illness
- Pfizer to Receive $296K In Fraud Case Restitution
- Forest Laboratories, Inc. Reports Fiscal Third Quarter 2010 Earnings Per Share of $0.69, Including One-Time Charges Totaling $0.28 Per Share
January 20, 2010
- GSK Offers Scientists Labs, Data to Fight Malaria
- More States Took in Expired Meds in 2009
- Alcon Independent Director Committee Determines Novartis' Merger Proposal to Minority Shareholders of Alcon is Grossly Inadequate
- Teva Reported Among Final 3 Bidders for Ratiopharm
- Panel of Alcon Directors Rejects Novartis Bid
- ConjuChem to Evaluate Strategic Alternatives
- Group Urges Recall Of Drug for Fibromyalgia
- Court Finds J&J Patents Invalid
- America's Pharmaceutical Research Companies Donate $20 Million to Relief Efforts in Haiti; More Help Coming
January 21, 2010
- Court Voids J&J Patents in Boston Scientific Suit
- MS Pills Show Promise and Risk, Studies Say
- Pfizer Close to Purchase of German Generics Firm
- Interpublic Announces Management Succession at McCann Worldgroup
- Auxillium to Get $15 Million Payment From Pfizer
- Study: Orphan Drug Applications Doubled In 200s
- NIH Toughens Rules On Baylor College Of Medicine [Houston Chronicle]
- After Starlims, Abbott Seeks More Israeli Acquisitions
January 22, 2010
- Tanabe Sets New Course For La Jolla Laboratories
- Lupin Plants Get USFDA Nod; Co to Sell New Products [The Economic Times, India]
January 25, 2010
- Alizé Pharma signs research collaboration and license option agreement with Lilly
- 3 Minnesota Bills Tackle Drug Costs, Prescription Practices
- Teva Increases Lobbying Ahead Of US Reform
- Bayer to Discontinue Phase II Clinical Trial for Long-Acting Recombinant Factor VIII Following Interim Analysis
- Quintiles Announces New Positioning, New Brand Identity
January 26, 2010
- Drug Companies Oppose Medicine 'take-back' Proposal
- Novartis Says Q4 Profit Rises 54 Percent to $2.32 Billion
- Sanofi-aventis Obtains Antitrust Clearance in Connection With Chattem, Inc. Tender Offer
- Amgen 4Q Profit Rises One Percent with Sales Steady
- Minnesota Legislators Seek New Drug Industry Controls
- NY Gov Wants New Regs on Gifts to Docs
- J&J Sales Climb, But Profit Falls on Big Charge
January 27, 2010
- Gilead 4Q Profit Rises 43 Percent on Atripla Sales
- Velcade (bortezomib): Starting Dose Adjustments-Patients with moderate/severe Hepatic Impairment Should be Treated with Reduced Starting Doses, Closely Monitored
- Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Issues Strong Earnings Outlook for 2010
- Abbott Laboratories Profit Stays Flat In 4Q
- Gilead 4Q Profit Rises 43 Percent On Atripla Sales
- Spectrum Pharmaceuticals Terminates Ozarelix Development Program in Benign Prostate Hypertrophy (BPH) as It Continues to Prioritize Its Portfolio Strategy
- Gilead Sciences Announces Record Fourth Quarter and Full Year 2009 Financial Results
- U.S. District Court Rules Against Merck in Temodar (temozolomide) Patent Lawsuit
- Pfizer Pares, Refocuses Research After Wyeth Buy
January 28, 2010
- AstraZeneca Announces PLC Fourth Quarter and Full Year Results 2009
- AstraZeneca Reports Strong Rise in Earnings
- Drugmaker Eli Lilly Reports 4Q Profit, Sales Jump
- Amylin Posts Smaller 4Q Loss as Charges Decrease
- Miss. Senate Panel OKs Prescription for Cold Pills
- Lilly Reports Fourth-Quarter and Full-Year 2009 Results
- Bristol-Myers 4Q Profit Rises On Sales Boost, Gain
- Baxter International 4Q Profit Rises 1 Percent
- Celgene Sees 4Q Profit On Sales Boost, Lower Costs
- Biogen Idec Says Icahn Proposes 3 Nominees
- Franklin Co. Judge Awards $5.3 Million In Penalties against AstraZeneca
- NJ Governor Names 2 More Cabinet Members
January 29, 2010
- GlaxoSmithKline Fined $5.8 Million for Deceptive Marketing in Kentucky
- Spectrum Receives $16 Million in Payments
- US Bristol-Myers Is Not Takeover Target -- CEO
- Theravance Reports New Delay in Infection Drug OK
- Genzyme Boosts Power of Lead Independent Director
- SDI Reports: Annual Checkup Finds Healthy Gains with Cardiologists by Merck Sales Reps
